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Abstract
To date, gene-environment (GxE) interaction studies in depression have been limited to hypothesis-based candidate
genes, since genome-wide (GWAS)-based GxE interaction studies would require enormous datasets with genetics,
environmental, and clinical variables. We used a novel, cross-species and cross-tissues “omics” approach to identify genes
predicting depression in response to stress in GxE interactions. We integrated the transcriptome and miRNome proﬁles
from the hippocampus of adult rats exposed to prenatal stress (PNS) with transcriptome data obtained from blood mRNA
of adult humans exposed to early life trauma, using a stringent statistical analyses pathway. Network analysis of the
integrated gene lists identiﬁed the Forkhead box protein O1 (FoxO1), Alpha-2-Macroglobulin (A2M), and Transforming
Growth Factor Beta 1 (TGF-β1) as candidates to be tested for GxE interactions, in two GWAS samples of adults either with
a range of childhood traumatic experiences (Grady Study Project, Atlanta, USA) or with separation from parents in
childhood only (Helsinki Birth Cohort Study, Finland). After correction for multiple testing, a meta-analysis across both
samples conﬁrmed six FoxO1 SNPs showing signiﬁcant GxE interactions with early life emotional stress in predicting
depressive symptoms. Moreover, in vitro experiments in a human hippocampal progenitor cell line conﬁrmed a functional
role of FoxO1 in stress responsivity. In secondary analyses, A2M and TGF-β1 showed signiﬁcant GxE interactions with
emotional, physical, and sexual abuse in the Grady Study. We therefore provide a successful ‘hypothesis-free’ approach for
the identiﬁcation and prioritization of candidate genes for
GxE interaction studies that can be investigated in GWAS
datasets.Marco A. Riva and Carmine M. Pariante SHARED senior authorship.
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Introduction
Major Depressive Disorder (MDD) has a well-established
genetic contribution, although with a modest (30–40%)
heritability [1]. However, we have so far failed to identify
vulnerability genes for this disorder. Indeed, while genome
wide association studies (GWAS) have identiﬁed main
genetic effects for schizophrenia [2], autism [3], and bipolar
disorder [4], even very large GWAS meta-analyses have
failed to identify genome-wide signiﬁcant associations in
depression [5, 6]. Only recently, and using enormous data-
sets from more than 75 thousand individuals with depression
and 200 thousand healthy subjects, 15 genome-wide sig-
niﬁcant loci for MDD have been identiﬁed [7]. One of the
potential reasons behind this weak genetic effect is the fact
that individual genotypic variations may increase the risk of
depression only in the presence of exposure to life stressors
and other adverse environmental circumstances, a phenom-
enon named as ‘gene-environment (GxE) interaction’ [8].
Indeed, environmental factors, and in particular exposure to
adversities early in life, have been consistently implicated in
the pathophysiology of depression [9]. For example, in a
large study conducted by the Center of Disease Control with
over 9000 participants, Chapman et al. [10] reported a dose-
response relationship between the severity of experienced
childhood adversities and the lifetime presence of depressive
episodes or chronic depression. However, despite the epi-
demiological and clinical evidence conﬁrming these effects,
there is substantial variability in the outcomes of early life
stress, since not all people exposed to early adversities
develop depression later in life. GxE interactions may indeed
also explain why adverse environmental factors do not
increase the risk of depression in each and every individual.
Two of the most established examples of GxE interac-
tions linking stress to depression result from the hypothesis-
driven investigation of the serotonin transporter promoter
short/long polymorphism (5-HTTLPR) and of a functional
single nucleotide polymorphism (SNP) within the FK506-
binding protein 51 (FKBP5) gene. Caspi and colleagues
were the ﬁrst to show that individuals with one or two
copies of the short allele of the 5-HTTLPR exhibit more
depressive symptoms and suicidality in the presence of
stressful life events as compared with individuals homo-
zygous for the long allele [11]. Although not all the studies
have replicated these ﬁndings [12], this GxE interaction has
been shown to predict depression in individuals exposed to
childhood maltreatment [13, 14]. Similarly, many studies
have shown that a functional SNP within FKBP5
(rs1360780) interacts with childhood abuse to predict a
multitude of psychiatric phenotypes in adults, including
depression and post-traumatic stress disorder [15–19]. For
this latter gene, epigenetic mechanisms leading to different
cortisol reactivity to stress seem to explain these effects [20,
21]. These two examples of GxE interactions are built on
decades of hypothesis-driven research, and have been
instrumental in order to identify not only genetic variants
that increase the risk of depression, but also the potential
biological and molecular mechanisms underlying this
increased risk. However, as extensively discussed elsewhere
[8], this hypothesis-driven approach can only discover a
fraction of such potential existing genetic variants, and it is
at odds with the current strategy of using a hypothesis-free
approach to identify genes associated with disorders.
Of course, using GWAS data to test GxE interactions
would be a theoretically viable option, but it would require
enormous datasets with both exposure (such as life events)
and outcome (depression) data. To date, only two genome-
wide by environment interaction studies (GWEIS) have been
performed in this regard. Dunn and colleagues (2016) [22],
using data from the SHARe cohort of the Women’s Health
Initiative comprising more than 10 thousand African
Americans and Hispanics/Latinas, have examined genetic
main effects and GxE interactions with stressful life events
and social support in the development of depressive symp-
toms; however, only one interaction signal was genome-
wide signiﬁcant in African Americans (rs4652467 located
14 kb from CEP350), and it was not replicated. The second,
subsequent whole genome pilot study, performed in only
320 subjects characterized for recent stressful life events,
found no interaction that was genome-wide signiﬁcant [23].
In the current paper, we propose a different ‘omics-based’
approach to identify candidate genes for GxE interactions
studies in GWAS datasets, using cross-species and cross-
tissue biological prioritization strategies that limits the
number of investigated genes and thus enhances the statis-
tical power to identify signiﬁcant ﬁndings. In particular, we
have ﬁrst analyzed the transcriptome and miRNome data
from the hippocampus of adult rats exposed to prenatal stress
(PNS), a well-established model of early life stress leading to
depressive behavior and hypothalamic-pituitary-adrenal
(HPA) axis hyperactivity in adulthood [24], in order to
obtain a list of genes that are both modulated by PNS and
targeted by the miRNAs that are modulated by PNS. We
have then integrated the resulting genes list with tran-
scriptome data obtained from blood mRNA of human adults
who had suffered from childhood trauma, and analyzed the
overlapping genes list using network analysis, which iden-
tiﬁes genes and molecules that interact with each other
because of physical interaction or co-expression, or because
they are related in common signaling pathways. Finally, we
have tested the top network cluster of genes for GxE inter-
actions in order to examine the effects of early life stress on
depressive symptoms in adulthood, in two different clinical
samples from the Grady Trauma Project in Atlanta (USA)
[25] and the Helsinki Birth Cohort Study (Finland) [26, 27].
In vitro experiments in a human hippocampal progenitor cell
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line were also conducted to conﬁrm the role of the identiﬁed
genes in stress responsivity.
Material and methods
Animal model and clinical samples
Prenatal stress model (for transcriptomics and miRNomics
analyses)
PNS procedure was performed as already published [28–
30]; brieﬂy, pregnant dams in the last week of gestation
were restrained in a transparent Plexiglas cylinder, under
bright light, for 45 min, three times a day for 1 week.
Control pregnant females were left undisturbed in their
home cages. Male offspring from control and PNS groups
were killed at postnatal day (PND) 62 (early adulthood) for
whole hippocampal dissection (for further details see Sup-
plementary Material). Rat handling and experimental pro-
cedures were performed in accordance with the EC
guidelines (EC Council Directive 86/609 1987) and with the
Italian legislation on animal experimentation (D.L. 116/92),
in accordance with the National Institute of Health Guide
for the Care and Use of Laboratory Animals.
Subjects exposed to early life trauma (for transcriptomics
analysis)
We recruited volunteer subjects from the local population
living in the area served by the South London and Maudsley
NHS Trust, in south-east London. Childhood traumatic
events were assessed using the Childhood Experience of
Care Abuse Questionnaire (CECA-Q; [31]). All the
volunteers were screened using the Psychosis Screening
Questionnaire (to exclude any psychotic and psychotic-like
symptoms). We performed transcriptomic analyses in
20 subjects who reported at least two types of abuse
(separation and physical abuse= 40%; separation and sex-
ual abuse= 20%; physical and sexual abuse= 5%; physical
and emotional abuse= 5%) or one type of severe abuse
(physical abuse only= 20%; emotional abuse only= 5%;
sexual abuse only= 5%); and in 20 subjects matched for
age, gender and body mass index (BMI) with no history of
early life trauma. Mean age± SD was 27± 1.6 and 25± 0.9
(df= 15; ℵ2= 0.222, p-value= 0.3), and percentage of
females was 45% (7 F/13M) and 35% (9 F/11M) (ℵ2=
0.417, p-value= 0.5), respectively, in the subjects with and
without childhood trauma. We collected information about
current medications (one subject was taking oral contra-
ception and one was in treatment with mefenamic acid),
general health (asthma, eczema, frequent headaches, recent
infections), education, employment, nicotine, and cannabis
smoking; the two groups were not different for any of these
variables (data not showed).
Blood samples were collected by using PaxGene Blood
Tubes. After collection, blood samples were kept at room
temperature for 2 h, then at −20 °C for 2 days and then at
−80 °C until their processing. The project was approved by
the Local Ethical Committee and subjects signed a consent
form (for further details see Supplementary Material).
Grady trauma project (for GxE analysis)
In the Grady Trauma Project, recruited in Atlanta (Georgia,
USA), detailed trauma interviews were collected in a large
sample of 4791 adults (mean age± SD of 40.1± 13.9) with
high rates of current and lifetime PTSD. For this study, we
used the Childhood Trauma Questionnaire (CTQ), a 28-item,
psychometrically validated inventory assessing self-reported
levels of sexual, physical and emotional abuse [32]. The pre-
sence of moderate-severe sexual, physical and emotional abuse
was coded as described before [33]. Emotional abuse was used
for the main GxE analyses on early life emotional stress, across
both this and the Helsinki Birth Cohort Study. Depressive
symptoms were measured using the Beck Depression Inven-
tory (BDI) [34]. The institutional review board at Emory
University approved the study procedures. All participants
provided written informed consent before participating.
Helsinki birth cohort study (for GxE analysis)
Between 2001 and 2004, 1620 individuals (mean age± SD
of 61.5± 2.9) who were born at Helsinki University Central
Hospital between 1934 and 1944, and who were alive and
living in Finland in 1971, participated into a clinical
examination during which blood samples for DNA were
used to obtain GWAS data for both directly genotyped and
imputed SNPs. Depressive symptoms were measured using
the BDI [34]. Early life emotional stress in this samples was
deﬁned as separation from biological parents in 1939–1946,
during the second world war, when around 80,000 Finnish
children were sent to Sweden and Denmark in order to
escape the dangers of war; 384 subjects were identiﬁed as
having been separated in childhood [26, 27, 35]. These
children were separated by both parents and their siblings at
the median age of 3.8 years (Range 0.6–10.1 years) for a
mean duration of 1.4 years (Range 0.2–4.7 years), thus
severely disrupting the attachment to signiﬁcant caregivers.
Previous studies in this cohort have clearly shown that these
subjects show worse mental health in adulthood. For
example, they report almost double the risk of experiencing
depressive symptoms over time [36] and have higher risks
of mental disorders, including substance abuse and per-
sonality disorders [37, 38]. Interestingly for the context of
our paper, they also show higher cortisol levels and more
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pronounced cortisol reactivity [39]. The project was
approved by the Local Ethical Committee (for further
details see Supplementary Material).
Biological assessments
mRNA and miRNA isolation from hippocampus of animals
and from the blood of subjects
Total RNA, including miRNAs, was isolated from rat brain
tissues by using RNeasy mini kit (Qiagen, Italy) and from
human blood samples using PaxGene miRNA kit (Qiagen,
Italy), according to the manufacturer’s instructions. Samples
were also treated with DNase, and RNA quantity and
quality was assessed by evaluation of the A260/280 and
A260/230 ratios using a Nanodrop spectrometer (NanoDrop
Technologies).
Whole Genome expression microarray analyses in the
hippocampus of animals and in the blood of subjects
Gene expression microarray assays were performed using
Rat Gene 2.1st Array Strips (which covers 27,147 coding
transcripts) or Human Gene 2.1st Array Strips (which covers
31,650 coding transcripts) on GeneAtlas platform (Affy-
metrix), following the WT Expression Kit protocol described
in the Affymetrix GeneChip Expression Analysis Technical
Manual, and as we have done before [28, 40] (for further
details see Supplementary Material). Of note, this is the ﬁrst
report of the rat hippocampal transcriptome following PNS
using the novel Rat Gene 2.1st Array Strips, hence we have
reported here all the relevant data and pathways analyses.
Real Time validation analyses of transcriptomic ﬁndings in
the hippocampus of animals and in the blood of subjects
All the genes that were signiﬁcantly modulated by stress
both in the hippocampus of animals and in the blood of
subjects (n= 22 genes, see Results Section) were validated
using Real-Time PCR by using Biorad qPCR Mix (BioRad,
Milan) and Taqman Assays on a 96 wells Real Time PCR
System (One Step TaqMan Real Time PCR). Each sample
was assayed in triplicate and each target gene was nor-
malized to β-actin and glyceraldehyde 3-phosphate dehy-
drogenase (GAPDH) in rodents, and to β−2-microglobulin
(B2M) and GAPDH in humans. The Pfafﬂ Method was
used to determine relative target gene expression.
MiRNome expression analysis in the hippocampus
of animals
Five hundred nanogram of total RNA (including miRNAs)
were processed with the FlashTag Biotin HSR RNA
Labeling kit (Affymetrix, Santa Clara, CA, USA) and
subsequently hybridized onto the GeneChip miRNA 4.1
Array Strip on a GeneAtlas platform (Affymetrix, Santa
Clara, CA, USA). The GeneChip miRNA 4.1 Array Strip
shows a comprehensive coverage as they are designed to
interrogate all mature miRNA sequences in miRBase
Release 20. Washing/staining and scanning procedures
were conducted on the Fluidics station following the man-
ufacturer’s instructions.
Genotyping of polymorphisms within the Grady Trauma
Study
DNA was extracted from saliva in Oragene collection vials
(DNA Genotek, Ottawa, ON, Canada) using the DNAd-
vance kit (Beckman Coulter Genomics, Danvers, MA,
USA), while DNA from blood was extracted using either
the E.Z.N.A. Mag-Bind Blood DNA Kit (Omega Bio-Tek,
Norcross, GA, USA) or ArchivePure DNA Blood Kit (5
Prime, Gaithersburg, MD, USA). N= 4,791 subjects were
genotyped on the HumanOmniExpress (6%) and the
Omni1-Quad BeadChip (94%) (Illumina Inc), and geno-
types were called with Illumina’s Genome Studio. The
HumanOmniExpress interrogates 730,525 individual SNPs
per sample, whereas the Omni1- Quad BeadChip inter-
rogates 1,011,219 individual SNPs (for further details see
Supplementary Material).
Genotyping of polymorphisms in the helsinki birth cohort
study
DNA was extracted from blood samples using Gentra Kit.
Participants were genotyped with the modiﬁed Illumina
610 k array, at the Wellcome Trust Sanger Institute, Cam-
bridge, UK according to standard protocols [38] (for further
details see Supplementary Material).
Statistical and bioinformatics analysis
Transcriptomic and miRNome statistical analysis
Raw data were imported and analyzed with the software
Partek Genomic Suite 6.6 (Partek, St. Louis, MO, USA). We
checked for quality control and batch effects using the
Principal Component Analyses (PCA) in the Partek Geno-
mic Suite Software, and we did not observe any outlier or
any batch effect, thus we did not correct for this. After
quality control of the data, Analysis of variance (ANOVA)
test was performed to assess the effects of PNS on genes
expression or miRNAs expression in rats, and of history of
early life adversities on gene expression in humans. A
maximum ﬁlter of p< 0.05 (FDR corrected) and a minimum
absolute fold change cut-off of 1.4 in animals and of 1.2 in
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humans was applied to select the lists of signiﬁcant genes.
The miRNAs-mRNAs combining analyses was performed
using a speciﬁc sub-feature in Partek Genomic Suite 6.6. For
blood transcriptome, possible differences in cell type
between the two groups were evaluated by using CellMix
package builds on R/BioConductor and available from http://
web.cbio.uct.ac.za/~renaud/CRAN/web/CellMix, and as we
have not detected differences in childhood trauma exposed
subjects as compared to non-exposed individuals we did not
use it as covariate.
Pathway analyses
List of signiﬁcant genes were analyzed for pathway ana-
lyses by using Ingenuity Pathway Analyses Software (IPA)
where, as a background, we used gene lists that we obtained
applying the minimum absolute fold change cut-off of 1.4
in animals and of 1.2 in humans and q-value <0.05.
Animal and human integration data
The genes lists deriving from rats (following miRNAs-
mRNAs combining analyses) and humans (mRNAs only)
were cross-integrated, and the list of common genes was
tested for random probability by Hyper-Geometric Dis-
tribution test [41] in R.
Network analyses
The list of common genes from animal and human data
were used for network analyses using speciﬁc tools in IPA.
GXE interactions
Grady trauma project
We transformed imputed genotypes to best guessed geno-
types using a probability threshold of 90%. To assess GxE
interaction, we individually tested each SNP within the
three genes of interest resulting from the ﬁnal network
analysis and also available in the Helsinki Birth cohort
study, for interactions between emotional stress (emotional
abuse) and BDI scores in adulthood, as a similar phenotype
was also present in the Helsinki Birth Cohort Study. Age,
gender, and the ﬁrst two principal components of the
identity-by-state (IBS) matrix were used as covariates in the
linear regression analyses in R. We made further adjust-
ments for SNP X covariate and child abuse X covariate
interactions, as suggested by Keller [42]. In addition, sec-
ondary analyses were conducted testing GxE interaction
between each type of childhood trauma (emotional, sexual
and physical abuse) and BDI scores in adulthood, in this
sample only.
Helsinki birth cohort study
We tested those SNPs within the three genes of interest
resulting from the ﬁnal network analysis that were also
available in the Grady Trauma Project, for interactions
between emotional stress (whether the individual was sepa-
rated from parents during WWII, or not) and BDI scores in
adulthood, using linear regression analysis. Each SNP was
tested in a separate model; age at testing, gender, and the ﬁrst
three principal components of the IBS matrix, main effects of
the gene and the environment were used as covariates. We
made further adjustments for SNP× covariate and separation
status× covariate interactions, as suggested by Keller [42].
Meta-analyses
We ran a ﬁxed-effects meta-analysis combining the inter-
action results testing emotional stress in both cohorts, using
the R-package Rmeta. Meta-analysis p-values were cor-
rected for multiple testing using Bonferroni-correction over
all tested SNPs.
Cell culture, gene expression and neurogenesis assay
The immortalized, multipotent human fetal hippocampal
progenitor cell line, HPC0A07/03C (propriety of
ReNeuron), was used for all cellular and molecular analyses
(mRNA levels, neuronal proliferation). Details of this cell
line, the proliferation protocol, gene expression and
immunocytochemistry can be found in Supplementary
Information Materials and Methods.
Results
Transcriptomic changes in the hippocampus of adult
male rats following PNS
Our ﬁrst aim was to identify gene expression changes in the
hippocampus of male adult rats (at PND 62) that had been
exposed to PNS. We analyzed the entire transcriptome and
we found a signiﬁcant modulation of 916 genes in the
comparison with control animals (using 1.4< FC<−1.4,
q-value <0.05). We have visualized the most signiﬁcant
genes in a hierarchical clustering in Fig. 1, and listed the
916 signiﬁcant genes in Supplementary Table 1.
We then performed a pathway analysis on the sig-
niﬁcantly modulated genes, in order to identify the main
biological processes involved. We identiﬁed 49 biological
processes that were altered by the PNS exposure, including
some involved in neurodevelopment (Axonal Guidance
Signaling, Protein Kinase A Signaling, Glutamate Receptor
Signaling, Wnt/β-catenin Signaling, CREB Signaling in
FoxO1, A2M, and TGF-β1: predictors of early in life stress-associated depression
Neurons, Synaptic Long Term Depression, Synaptic Long
Term Potentiation, Glucocorticoid Receptor Signaling) and
inﬂammation (IL-8 Signaling, STAT3 Pathway, CDK5
Signaling, IL-1 Signaling, IL-6 Signaling, BMP signaling
pathway and TGF-β Signaling). All the signiﬁcant pathways
are summarized by the pie-chart detailing the relevant
functional areas (Fig. 2a), while the entire list of signiﬁcant
pathways is presented in Supplementary Table 2. We con-
ducted the subsequent target prioritization steps using the
full list of 916 differentially regulated genes.
Fig. 1 Hierarchical Clustering of
gene expression changes by
prenatal stress (PNS) in the
hippocampus of rats, in
comparison with control
animals. The red bar on the
horizontal axis indicates control
animals and the orange bar
indicates PNS-exposed animals.
The blue and the red squares in
each group (CTRL or PNS)
indicate the modulation of the
gene expression, with red
squares indicating genes that are
up-regulated and blue squares
gene that are down regulated
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MiRNome changes in the hippocampus of PNS rats,
and combined analyses with transcriptomic changes
We subsequently investigated whether exposure to PNS
causes changes in miRNAs levels, and whether the identi-
ﬁed miRNAs could target transcripts identiﬁed in the tran-
scriptomics analysis. After the selection of the species
(Rattus Norvegicus), we identiﬁed a total number of 1218
miRNAs (including pre-miRNAs and mature miRNAs); out
of these, 68 miRNAs (47 of them were mature miRNAs)
were signiﬁcantly modulated (all with q-value <0.05) in
animals exposed to prenatal stress, with sixty-ﬁve down-
regulated and only 3 up-regulated (see Table 1).
As both transcriptomic and miRNome analyses were
conducted in the hippocampus of the same animals, we then
performed a mRNA-miRNAs combining analysis that
allows the identiﬁcation of a panel of top-hit genes that
were both modulated by PNS exposure and targeted by the
miRNAs that were modulated by PNS (see Methods). These
analyses identiﬁed 528 signiﬁcant genes, presented in
Supplementary Table 3. The speciﬁc pathways analysis
shows that these were genes involved in neurodevelopment
(Axonal Guidance, Protein Kinase-A Signaling, Gluco-
corticoid Receptor Signaling, TGF-β Signaling) and
inﬂammation (STAT3 Pathway, PTEN Signaling, ILK
Signaling, IL-8 signaling); the full list of the 42 pathways is
presented in Supplementary Table 4.
Blood mRNA transcriptomics of early life trauma in
humans
Comparing subjects with and without exposure to early life
trauma (see Methods for sociodemographic and clinical
information), we identiﬁed 250 genes that were differen-
tially modulated (FC> 1.2, FDR q-value <0.05) (see Sup-
plementary Table 5), involved in the modulation of 41
signiﬁcant pathways. Of note, these were, again, pathways
involved in neurodevelopment (Wnt/Ca+ pathway, cAMP
signaling, CREB signaling) and inﬂammation (eNOS sig-
naling, chemokine signaling, B cell activation), similar to
Fig. 2 a Pathways pie chart in
prenatally stressed animals. The
pie chart represents the
functional relevance of the
signiﬁcant pathways found
modulated in the hippocampus
of PNS-exposed adult rats. b
Pathways pie chart in adults with
a history of childhood trauma.
The pie chart represents the
functional relevance of the
signiﬁcant pathways found
modulated in the blood of adult
subjects exposed to childhood
trauma
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what we found in the PNS model. All the signiﬁcant
pathways are summarized by the pie-chart detailing the
relevant functional areas in Fig. 2b, and listed in Supple-
mentary Table 6.
Integrating data from PNS in animals and from early
life trauma in humans
In the next step, we integrated the 528 genes obtained by
combined mRNA/miRNA analyses in the hippocampus of
rats exposed to PNS with the 250 genes signiﬁcantly
modulated in the blood of adults exposed to early life
trauma. We identiﬁed 22 common genes that were present
in both lists; according to the hypergeometric distribution
test, the probability that these genes were not overlapping
due to random probability was p= 1.8× 10–8.
Finally, we validated all of the 22 genes by Real–Time
PCR, both in the hippocampus of animals and in the blood
of adults exposed to childhood trauma. In line with the
microarray results, 16 genes were modulated in the same
direction both in the rat hippocampus and in the human
blood, and 6 were modulated in the opposite direction.
Speciﬁcally, 15 were up-regulated in both: Alpha-2-
Macroglobulin (A2M), AT-Rich Interaction Domain 5B
Table 1 List of miRNAs (both mature and non-mature miRNAs)
signiﬁcantly modulated (all with q-value <0.05) in animals exposed to
prenatal stress, compared with control animals
miRNA name Fold-change
1 rno-miR-3473 –1,7
2 rno-mir-3593 –1,2
3 rno-miR-339–5p –1,4
4 rno-mir-1839 –1,2
5 rno-mir-3556b –1,2
6 rno-miR-133b-5p –1,3
7 rno-miR-1839–5p –1,2
8 rno-mir-322 –1,3
9 rno-mir-425 –1,2
10 rno-mir-18a –1,3
11 rno-mir-3085 –1,3
12 rno-mir-329 –1,2
13 rno-miR-370–3p –1,4
14 rno-miR-181c-5p –1,3
15 rno-miR-872–3p –1,5
16 rno-miR-423–3p –1,6
17 rno-miR-93–3p –1,6
18 rno-mir-872 –1,3
19 rno-miR-152–3p –1,4
20 rno-mir-448 –1,3
21 rno-miR-3068–3p –1,4
22 rno-mir-532 –1,3
23 rno-mir-290 –1,2
24 rno-miR-106b-3p –1,4
25 rno-mir-27b –1,2
26 rno-mir-203a 1,3
27 rno-miR-362–5p –1,5
28 rno-miR-877 –1,4
29 rno-miR-7a-1–3p –1,5
30 rno-miR-135b-3p –1,5
31 rno-miR-6328 –1,2
32 rno-miR-540–3p –1,4
33 rno-mir-376a –1,2
34 rno-miR-10b-5p –1,3
35 rno-miR-425–3p –1,5
36 rno-miR-330–5p –1,4
37 rno-miR-6326 –1,3
38 rno-mir-764 –1,3
39 rno-miR-200a-5p –1,2
40 rno-mir-494 –1,2
41 rno-mir-379 –1,3
42 rno-miR-151–3p –1,2
43 rno-miR-28–3p –1,5
44 rno-miR-15b-5p –1,4
45 rno-miR-324–3p –1,3
Table 1 (continued)
miRNA name Fold-change
46 rno-miR-871–3p 1,2
47 rno-miR-214–3p –1,4
48 rno-mir-101b –1,3
49 rno-miR-325–5p –1,3
50 rno-miR-339–3p –1,4
51 rno-mir-196c –1,4
52 rno-miR-6324 –1,6
53 rno-miR-19b-3p –1,4
54 rno-miR-20b-5p –1,6
55 rno-miR-666–3p –1,5
56 rno-miR-351–5p –1,2
57 rno-miR-99b-3p –1,3
58 rno-mir-135a –1,3
59 rno-miR-139–3p –1,4
60 rno-miR-342–5p –1,3
61 rno-miR-376b-3p –1,3
62 rno-miR-450a-5p 1,3
63 rno-miR-140–5p –1,6
64 rno-miR-493–3p –1,5
65 rno-miR-532–5p –1,3
66 rno-miR-124–5p –1,3
67 rno-miR-1843–5p –1,3
68 rno-miR-6215 –1,3
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(ARID5B), Arrestin Domain Containing 4 (ARRDC4),
EPH Receptor A4 (EPHA4), F-Box Protein 32 (FBXO32),
Forkhead box protein O1 (FoxO1), Heat Shock Transcrip-
tion Factor 2 (HSF2), Isochorismatase Domain Containing
1 (ISOC1), Low Density Lipoprotein Receptor Adapter
Protein 1 (LDLRAP1), Leucine-rich repeat neuronal protein
3 (LRRN3), Myosin ID (MYO1D), Phosphatidylinositol-4-
Phosphate 3-Kinase, Catalytic Subunit Type 2 Beta
(PIK3C2B), Phosphatidic Acid Phosphatase Type 2A
(PPAP2A), Sterile Alpha Motif Domain Containing 12
(SAMD12), and Serine Incorporator 5 (SERINC5); one was
down-regulated in both: Transforming Growth Factor, Beta
1 (TGF-β1); one was up-regulated in rats and down-
regulated in humans: Solute Carrier Family 24 (Sodium/
Potassium/Calcium Exchanger) Member 3 (SLC24A3); and
5 were down-regulated in rats and up-regulated in humans:
B-Cell CLL/Lymphoma 2 (BCL2), B-Cell CLL/Lymphoma
9 (BCL9), Lymphoid Enhancer-Binding Factor 1 (LEF1),
Lin-54 DREAM MuvB Core Complex Component
(LIN54), and Post-GPI Attachment to Proteins 1 (PGAP1).
These genes are presented in Supplementary Table 7, where
we also present the FCs obtained from the microarray stu-
dies and the FCs from Real Time PCR analyses. For all the
above-mentioned molecular and biochemical analyses, all
data met the assumptions of normal distribution and
equality of variance.
Gene network analysis and selection of candidates
for GxE interaction
We focused on the 16 genes (A2M, ARID5B, ARRDC4,
EPHA4, FBXO32, FoxO1, HSF2, ISOC1, LDLRAP1,
LRRN3, MYO1D, PIK3C2B, PPAP2A, SAMD12, SER-
INC5, and TGF-β1) that were modulated in the same
direction both in animals and in humans, and we applied a
gene network analysis to identify possible interactions
among these genes. Indeed, our main theoretical framework
was based on the notion that depression is a complex dis-
order, where multiple genes interact with each other as
belonging to common or overlapping signaling systems.
Therefore, also to minimize any chance ﬁndings, we deci-
ded a priori to select, for the subsequent GxE interaction
analyses, only those genes that interacted with each other
through physical interaction, co-expression or involvement
in common pathways.
Using IPA Software, we observed only one cluster of
interacting genes, represented by A2M, FoxO1 and TGF-β1
(Fig. 3). Using a gene enrichment/pathway analysis, we
then conﬁrmed that this cluster is involved in cytokines
signaling, TGF- β1 signaling and glucocorticoid receptor
signaling. As we found that A2M, FoxO1, and TGF-β1 form
a single individual cluster of genes interacting with each
other, we focused on these three genes for the subsequent
GxE studies.
Gene X environment interaction studies
For our main analyses, we focused on all the SNPs located
in these three genes and available in both the Grady Trauma
Project and Helsinki Birth cohort (FoxO1, n= 132 SNPs;
A2M, n= 91 SNPs; and TGF-β1, n= 14 SNPs), and we
tested their interaction with emotional stress in childhood in
predicting depressive symptoms in adulthood (BDI scores)
for both cohorts (Table 2). Then, we assessed the combined
effect over both cohorts and performed a meta-analysis (See
Supplementary Table 8). The meta-analyses indicated that 6
SNPs, all located within the FoxO1 gene, were signiﬁcantly
associated with emotional stress in predicting depressive
symptoms, and also survived multiple testing correction for
GxE interactions, with the SNP rs17592371 showing the
strongest signiﬁcance (p= 0.003, Bonferroni correction).
For all the 6 SNPs, p-values for heterogeneity of effects
were not signiﬁcant, indicating that ﬁxed-effects meta-
analysis was justiﬁed. The GxE interaction effect for the
SNP rs17592371 in both cohorts is presented in Fig. 4,
where we can see that individuals with “at risk” genotypes
(CC) developed more depressive symptoms in the presence
of early separation as compared to individuals with the “low
risk” genotypes (CT and TT).
We also conducted additional, secondary analyses on
these three genes, in the Grady Trauma Project sample,
because it has a wider range of abuse phenotypes. Speciﬁ-
cally, we tested the interaction between childhood sexual,
Fig. 3 Network Analyses on the 16 common genes between rats and
humans. Network Analyses of the 16 common genes modulated in the
same direction both in the hippocampus of rats exposed to prenatal
stress and in the blood of adults exposed to childhood trauma. The blue
lines indicate direct interactions between molecules (A2M, FoxO1,
and TGF-β1). The dot lines indicate the involvement of molecules
within pathways
FoxO1, A2M, and TGF-β1: predictors of early in life stress-associated depression
physical or emotional abuse, and depressive symptoms in
adulthood (BDI scores). Within FoxO1, 6 SNPs showed
signiﬁcant GxE interactions with sexual abuse, 40 SNPs
with physical abuse and 40 SNPS with emotional abuse
(although with a large overlap between SNPs); within A2M,
7 SNPs showed signiﬁcant GxE interactions with emotional
abuse; and within TGF-β1, 4 SNPs showed signiﬁcant GxE
interactions with sexual abuse and 1 SNP with emotional
abuse (See Supplementary Table 9).
FoxO1 is activated in hippocampal progenitor stem
cells following cortisol exposure, and it mediates
the negative effect of stress on neurogenesis
As FoxO1 was up-regulated both in the hippocampus of
animals exposed to PNS and in the blood of subjects exposed
to childhood trauma, and it was also the most signiﬁcant gene
from our GxE analyses across the two clinical cohorts, we
decided to test the functional relevance of this gene. Speciﬁ-
cally, we wanted to test: 1) whether the stress-induced FoxO1
upregulation could be replicated in vitro upon treatment with
the human stress hormone, cortisol, using our established
model of ‘depression in a dish’, the immortalized, multipotent
human fetal hippocampal progenitor cell line (HPC0A07/
03C); and 2) whether FoxO1 is involved in the cortisol-
induced reduction of neuronal proliferation that we had pre-
viously described in this model [28].
Consistent with our hypothesis, FoxO1 mRNA levels
were signiﬁcantly increased following 24 h of treatment
with 100 μM cortisol (FC=+ 3.9, p< 0.0001, Fig. 5a).
Moreover, the cell-permeable inhibitor of FoxO1,
AS1842856 (100 nM), was able to completely inhibit the
cortisol-induced upregulation of FoxO1 (Fig. 5a) and the
cortisol-induced reduction in neuronal proliferation (BrdU
+ cells; one-way ANOVA, p= 0.01 versus cortisol,
Fig. 5b, c). AS1842856 alone did not exert any effects on
proliferation (p= 0.9), indicating that FoxO1 mediates the
effect of stress, but it is not active under baseline conditions.
Finally, in order to investigate the molecular pathways
by which FoxO1 signaling regulates the effects of stress on
neuronal proliferation, we measured also the mRNA levels
of a stress- and cortisol-induced gene, the Serum Gluco-
corticoid Kinase 1 (SGK-1), again following cortisol with
or without AS1842856. SGK1 is a stress responsive gene
that mediates some of the glucocorticoid effects on brain
function [43], including the negative effects of cortisol on
neurogenesis [28], and we found that SGK1 is elevated in
both the hippocampus of stressed rats and in the blood of
depressed patients [44]. We found that 24 h of cortisol (100
uM) treatment up-regulates SGK1 mRNA levels (FC=+
3.7, p< 0.0001, Fig. 5a), replicating again our previous
ﬁndings [44], and that AS1842856 was able to counteract
such changes (Fig. 5a).
Discussion
We provide a novel ‘hypothesis-free’ approach for the
identiﬁcation and prioritization of candidate genes that can
Table 2 Gene X Environment interactions in the two clinical samples
for the six genes identiﬁed to be associated with emotional stress in the
Grady Trauma Project and in the Helsinki Birth Study Cohort
GENE SNPs FOXO1 Grady Trauma
Project
Helsinki Birth
Study Cohort
β score p-value β score p-value
FoxO1 rs17592371 –3,035 <0,0001 –1,780 0,033
FoxO1 rs2297626 –2,601 0,0002 –1,808 0,037
FoxO1 rs17592468 –2,549 0,0003 –1,763 0,034
FoxO1 rs28553411 –2,549 0,0003 –1,763 0,034
FoxO1 rs7319021 –2,549 0,0003 –1,763 0,034
FoxO1 rs12585452 –2,416 0,0007 –1,796 0,032
11
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23
25
no Emoonal lanoitomEesubA Abuse
CC CT/TT
4
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Fig. 4 Interaction effect between rs17592371 and stress on BDI
symptoms. Estimated marginal means of BDI scores for different
genotypes of the FoxO1 single nucleotide polymorphism rs17592371
in subjects who were or were not exposed to emotional abuse in the
Grady Trauma Project (on the left) and in the Helsinki Birth Study
Cohort (on the right). Values are adjusted for gender and age
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be investigated in GWAS datasets to test GxE interaction
studies in depression. In particular, by employing “omics”
approaches in animals (mRNAs and miRNAs) and in
humans (mRNAs), and cross-species validation, we have
identiﬁed one cluster of genes, comprising FoxO1, A2M,
and TGF-β1, that show signiﬁcant GxE interactions pre-
dicting adult depression in the context of early life trauma in
our study, and have also been previously involved in the
regulation of mechanisms relevant to stress and depression
[45–49]. Our main ﬁndings, conﬁrmed by a meta-analysis
run on both cohorts, indicate that several SNPs within
FoxO1 interact with emotional stress during childhood in
predicting adult depression, both in the Grady Trauma
Project, as well as in the Helsinki Birth Cohort Study.
Importantly, we also describe a functional role of FoxO1 in
stress responsivity in our in vitro model of human hippo-
campal progenitor cells. In addition, secondary analyses
show that several SNPs within FoxO1, A2M, and TGF-β1
interact with emotional, physical and sexual abuse in pre-
dicting adult depression in the Grady Trauma Project.
A large body of evidence has rapidly accumulated over
the past years describing interactive effects of genetic fac-
tors and early life stressors in determining the risk of
depression [8]. These ‘hypothesis-driven’ studies have
mostly focused on genetic variations in candidate genes
acting in neurobiological systems that have been previously
implicated in the pathophysiology of major depression. As
mentioned in the Introduction, the most consistent examples
of this approach are studies examining the 5-HTTLPR SNP
in the serotonin transporter [13, 50–53] and several func-
tional SNPs within FKBP5 [17, 18]. However, numerous
studies, and some meta-analyses, have produced discrepant
results [50, 54–56]. New gene-environment interactions
continue to be reported in psychiatry, including in genes as
biologically varied as BDNF [57, 58], CD38 [59],
ADCYAP1R1 [60], DRD2 [61] and GRIN2B [62], but
always from hypothesis-driven research, which has a high
risk of non-replication. Indeed, considering the current
emphasis on omics-based approach in genetic-research, and
especially in the context of a paucity of signiﬁcant genetic
effects for depression in GWAS studies, other statistical and
biological prioritization strategies need to be developed to
facilitate a systematic discovery of novel gene-environment
interactions in genome-wide analyses. To our knowledge,
the present study is the ﬁrst report of a hypothesis-free,
omics-, cross-tissues and cross-species approach to identify
candidate genes for GxE interaction analyses. Interestingly,
Mamdani and colleagues (2015) [63] recently used a similar
approach to detect genes of interest in the context of alcohol
dependence, combining data from mRNA and miRNA
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Fig. 5 Cortisol treatment (100 μM) increases FoxO1 and SGK1
mRNA levels and decreases neurogenesis via a FOXO1-dependent
effect. a Gene expression levels of FoxO1 and of SGK1. b BrdU
immunocytochemistry was used to assess proliferation. c The FOXO1
inhibitor, AS1842856 (100 nM) counteracted the CORT-induced
reduction in proliferation (n= 5). Data are mean± SEM **p< 0.01;
***p< 0.001
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expression patterns in the brain of 18 patients with alcohol
dependence and 18 matched controls; although they did not
test for GxE interactions, they identiﬁed a network of hub
genes that was enriched for genes identiﬁed by the Alcohol
Dependence Genome Wide Association Study.
Our strongest ﬁndings, replicated in both clinical cohorts,
pertain to FoxO1. FoxO1 belongs to the forkhead family of
transcription factors, which are characterized by a distinct
forkhead domain; it is the main target of insulin signaling, it
regulates metabolic homeostasis in response to oxidative
stress, it is modulated by glucocorticoids and it enhances
inﬂammation [64]. It is also an important regulator of cell
death acting downstream of Cyclin-dependent kinase 1
(CDK1), AKT Serine/Threonine Kinase 1 (AKT1) and
macrophage stimulating 1 (MST1), and indeed several
studies have suggested that activation of FoxO1 contributes
to glucocorticoid-induced cell death [65]. Importantly,
FoxO1 is also involved in the maintenance of human
embryonic stem cells pluripotency, a function that is
mediated through direct control by FoxO1 of OCT4 and
SOX2 gene expression, through occupation and activation
of their respective promoters.
The six FoxO1 SNPs that were found associated with
emotional stress in both cohorts are intronic SNPs, and
therefore the mechanisms of action remain unclear,
although likely affecting gene expression and not the
function of the gene product. It is also possible that these
SNPs can inﬂuence the protein conformation or the acces-
sibility to phosphorylation sites. Indeed, a number of
kinases can phosphorylate and regulate FoxO1 proteins
either positively or negatively [66–68], including AKT
serine/threonine protein kinase downstream of the PI(3)K
(phosphatidylinositol-3-OH kinase) signaling pathway [69,
70], as well as SGK1, a kinase that is speciﬁcally activated
by stress, glucocorticoids and depression. In particular,
SGK1 phosphorylates FoxO1 at different sites, leading to
subcellular redistribution of FoxO1 from the nucleus to the
cytosol [71, 72]. Of note, we have previously described that
SGK1 mediates the inhibitory effect of glucocorticoids on
neurogenesis, and that its blood mRNA expression levels
are elevated in patients with major depression [28]. More-
over, in the present paper we show that the glucocorticoid,
cortisol, induces the mRNA levels of both FoxO1 and
SGK1, and that an inhibition of FoxO1 prevents the SGK1
upregulation, indicating that this could be dependent on
FoxO1, and thus that SGK1 may represent a novel target
gene for FoxO1. Interestingly, Kaiser et al., [65] had shown
similar ﬁndings in mouse pancreatic islet cells, although
their paper only identiﬁed FoxO1 as a target of SGK1, and
not vice versa. Taking into account also this last study, it is
possible to speculate that FoxO1 activation during stress
stimulates SGK1 activation, which could then further
enhance FoxO1 phosphorylation.
There is some limited evidence already for a role of
FoxOs in psychiatric disorders. Indeed FoxOs, especially
FoxO6, are mainly expressed in hippocampus, amygdala
and nucleus accumbens, which are important brain areas
involved in aversive and rewarding responses to emotional
stimuli [73, 74], suggesting that FoxOs may be involved in
the regulation of mood and emotion. Moreover, FoxOs are
regulated by antidepressants, as well as serotonin and nor-
epinephrine receptor signaling [75]. Indeed, FoxO3a has
emerged as a candidate gene involved in bipolar and uni-
polar disorders [76]. Moreover, in a learned helplessness
animal model, inescapable shocks signiﬁcantly reduce the
phosphorylation of FoxO3a and induces the nuclear loca-
tion of FoxO3a in the cerebral cortex; moreover, learned
helplessness behavior is markedly diminished in FoxO3a-
deﬁcient mice [77]. These results are consistent with the
report that FoxO3a inﬂuences behavioral processes linked
to anxiety and depression, and that FoxO3a- deﬁcient mice
show reduced depressive behavior [78] while FoxO1 KO
mice displayed reduced anxiety [78] behavior. This is in
line with our ﬁnding in the present paper, as we describe
higher levels of FoxO1 in the brain of rats exposed to
prenatal stress, in the blood of subjects exposed to child-
hood trauma, and in cells treated with the stress hormone,
cortisol; moreover, in vitro FoxO1 mediates the cortisol-
induced reduction of neuronal proliferation. Together, these
data indicate that enhanced levels of FoxO1 due to stress
exposure are associated with enhanced vulnerability to
develop stress related disorders.
The ﬁndings that both A2M and TGF-β1 have SNPs with
signiﬁcant GxE interactions in the Grady Trauma Project,
albeit limited by the secondary nature of the analyses and
the lack of a replication sample, still are of some interest, as
both genes have been implicated in biological processes
relevant to depression. A2M has traditionally been viewed
as an inﬂammatory ﬂuid proteinase scavenger, and recent
studies have demonstrated the ability of A2M to bind to a
plethora of cytokines, including TGF-β1 [79]. TGF-β1, in
turn, is a member of TGF-β superfamily, which regulates
neuronal survival, neurogenesis, synaptogenesis and glio-
genesis [80–83]. Similar to the present study, where we
found increased A2M mRNA levels following stress both in
the rodent hippocampus and in the human blood, A2M is
elevated in clinical samples and in experimental models
relevant to depression; for example, higher levels of blood
A2M are present in patients with total gastrectomy that
develop depression, indicating that A2M elevation may be
implicated in depression pathogenesis in the context of a
pro-inﬂammatory status [84]; and ﬁshes subjected to the
stress of repeated emersions show higher blood levels of
A2M [85]. High levels of A2M have indeed been associated
with systemic inﬂammation [86], and therefore it is possible
to speculate that the high levels of A2M described in this
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and other studies may translate into an increased risk of
depression by activating the inﬂammatory system [40, 87,
88]. TGF-β1, in contrast, is reduced in conditions related to
stress and depression, in the present study, as well as in
previous studies. For example, TGF-β1 levels are reduced in
the blood of depressed patients [89–91], and we have pre-
viously shown that the TGF-β1-SMAD signaling is one of
the pathways that is most signiﬁcantly down-regulated in
neurons by in vitro exposures to high concentrations of
cortisol, which mimics depression in vitro and negatively
affects neurogenesis [28]. Finally, is of note that several
SNPs within A2M and TGF-β1, including those that we
have identiﬁed through our GxE interaction analyses, are
associated with the development of several Complex Dis-
eases and Disorders (see genetic association database from
complex diseases and disorders https://geneticassocia
tiondb.nih.gov). Moreover, genetic variants in TGF-β1
have been associated with other brain disorders, such as
multiple sclerosis [92] and Alzheimer disease [93, 94].
It is important to emphasize that GxE interactions, while
based on the effects of speciﬁc changes in DNA sequence,
are likely to involve epigenetic mechanisms [95–97]. For
example, recent studies have shown that the above-
mentioned functional polymorphism in the FKBP5 gene
increases the risk of developing depression and PTSD in
adulthood by allele-speciﬁc, childhood trauma–dependent
DNA demethylation in functional glucocorticoid response
elements of FKBP5, followed by a long-term dysregulation
of the stress hormone system and a global effect on the
function of immune cells and of brain areas associated with
stress regulation [98]. Besides DNA methylation, miRNAs
have also recently emerged as important in the long-term
regulation of gene expression associated with stress early in
life [99–103]. The ability of miRNAs to selectively and
reversibly silence the mRNAs of their target genes [104,
105], together with their involvement in biological processes
modulated by stressful life events [106], make miRNAs
well-suited to serve as ﬁne regulators of the complex and
extensive molecular network involved in stress response;
hence, our decision in this paper of merging transcriptomics
and miRNomics data in the selection of top-hit genes.
There are two limitations in our study that should be
mentioned. First, only interactions with emotional stress
were tested in both samples, and six FoxO1 SNPs survived
multiple-testing correction and were conﬁrmed by meta-
analysis; the other SNPs in FoxO1, A2M and TGF-β1 that
were associated with multiple types of abuse were only
tested in the Grady Trauma sample, in secondary analyses.
We trust that the use of a different clinical population (the
South-East London sample) to generate transcriptomics,
together with the cross-species validation, support the
relevance of all of our ﬁndings, including the evidence for
A2M and TGF-β1, but clearly these secondary analyses are
only exploratory at this stage. Second, the samples size of
the cohort of adult subjects with a history of childhood
trauma used for transcriptomic analyses is relatively small,
with n= 20 subjects per group. However, to the best of our
knowledge, this is the ﬁrst gene expression microarray
study comparing the transcriptome in subjects exposed to
childhood trauma versus non-exposed individuals, and thus
provides informative ﬁndings. Moreover, the validity of our
transcriptomics results is strengthened by the fact that we
compare subjects not exposed to early life trauma with
subjects exposed to the most severe types of trauma or to
more than one traumatic event, thus maximizing the bio-
logical differences between the two groups. Finally, only
the genes regulated also in the animal brains were selected
for the further genetic association analyses, again
strengthening the validity of our ﬁndings. All together,
these lines of evidence defend the appropriateness of our
sample size for the transcriptomics analyses.
In conclusion, our data provide a novel approach for the
selection of novel susceptibility genes for GxE interaction
in depression, alternative to ‘hypothesis-driven research’ and
resulting in the prioritization of candidate genes starting
from a ‘hypothesis-free’ approach. The evidence that the
three identiﬁed genes all interact with environmental stress
in inducing depressive symptoms, and that the statistically
strongest gene, FoxO1, has functional relevance in stress-
induced reduction of neurogenesis, support our theoretical
framework. We propose that our prioritization strategy will
limit the number of investigated genes in GWAS-based
GxE interaction studies and thus will enhance the statistical
power to identify signiﬁcant ﬁndings. Moreover, we pro-
pose that FoxO1 may represent a target for the development
of novel pharmacological therapies to prevent or treat
stress-induced mental disorders.
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